Previous studies have shown that the human papillomavirus type 16 (HPV-16) L2 capsid protein plays an essential role in viral infection, in part through its interaction with sorting nexin 17 (SNX17). We now show that this interaction between L2 and SNX17 is conserved across multiple PV types. Furthermore, we demonstrate that SNX17 is essential for infection with all PV types analyzed, indicating an evolutionarily highly conserved virus entry mechanism.
M
any of the more than 120 known human papillomaviruses (HPVs) cause sexually transmitted infections, with a subset of them being associated with the development of epithelial tumors and cancer (1) . Infectious entry of HPVs is still poorly characterized in terms of the cellular proteins and endocytic pathways employed. It seems that some HPV types may have evolved different entry strategies (2, 3) or take advantage of cross talk between different routes of endocytosis (4, 5) . A recent study suggested that HPVs can usurp soluble cellular factors for interaction with a plethora of entry receptors, resulting in different routes of internalization (6) . The HPV capsid, comprising the major L1 and minor L2 proteins, fulfills various roles in the establishment of a successful viral infection. L2 is critically involved in many steps of the infection process, although its precise functions in entry, intracellular trafficking, endosomal escape, and nuclear import of the viral genome have not been fully elucidated (7) . While L2 is not essential for viral uncoating, it is critical for the escape of viral DNA from the endosomal compartment (8) and ultimately for aiding transport of the viral genome to the nucleus (9-11).
We reported previously that the HPV-16 L2 interaction with a member of the sorting nexin family, SNX17, is essential for HPV-16 infection (12) . SNX17 is localized in early endosomes and recycling tubules and is primarily involved in endosomal recycling (13, 14) . We showed that at least one putative SNX17 binding motif, NPxF/Y (PTB consensus binding motif) is present in L2s from diverse papillomavirus (PV) genera, indicating that this motif is evolutionarily highly conserved. A previous protein mass spectrometry analysis of HPV-11 L2 and HPV-16 L2 immunoprecipitates in HEK293 cells revealed that SNX17 is an interacting partner of both L2 proteins (12) . To investigate whether SNX17 interacts with L2 proteins from diverse HPV genera, a series of pulldown assays with a panel of glutathione S-transferase (GST)-L2 proteins and endogenously derived SNX17 were performed. The results (Fig. 1A) confirmed the interaction between HPV-16 and HPV-11 L2 (genus Alpha) proteins and SNX17. The analysis was then extended to HPV-5 L2 (genus Beta), bovine papillomavirus type 1 (BPV-1) L2 (genus Delta), and cottontail rabbit papillomavirus type 1 (SfPV-1) L2 (genus Kappa). The results in Fig. 1A show interactions between these diverse L2 proteins and SNX17, although the interaction between SNX17 and SfPV L2 was consistently weaker.
Previous analyses indicated that HPV-16 L2 bound SNX17 through the consensus SNX17 recognition motif (NPxF/Y) at position 254. However, as can be seen in Fig. 2A , multiple sequence alignments of the different L2 protein sequences showed that all L2 proteins possess multiple short motifs (NPxF/Y) and at least one extended binding motif (F/YxNPxF/ Y), which has been shown to be important for SNX17 interaction with P-selectin (15) and amyloid precursor protein (16) . To further characterize the SNX17 binding site on HPV-16 L2, we generated two mutants where the two predicted SNX17 binding sites, 160 NPTF and 254 NPAY, were replaced with alanines. Hemagglutinin (HA)-FLAG-tagged HPV-16 L2 was then expressed in HEK293 cells, and binding to SNX17 was evaluated in a GST-SNX17 pulldown assay. Figure 1B shows that the interaction between HPV-16 L2 and SNX17 was not affected by mutation of the NPTF motif at position 160; however, substitution of the second motif, NPAY, at position 254 almost completely abolished the interaction with SNX17. These results highlight the primary importance of the extended binding motif (F/YxNPxF/Y) in HPV-16 L2. This also suggests that L2 proteins, which possess multiple versions of this motif, such as HPV-5 L2, might interact more strongly with SNX17. However, this does not provide an explanation for the weaker interaction between SfPV L2 and SNX17, but that could be related to single amino acid variations within the consensus motif. It is also worth noting that the consensus interaction motif could, in some HPV types, be regulated by phospho-tyrosine modification. So far we have no evidence that this occurs for HPV-16 L2, although further studies are warranted.
To investigate the role of SNX17 in PV infection, we employed a model system of PV pseudovirions (PsVs) harboring a reporter plasmid carrying the luciferase gene (17) . Figure 2A shows the selection of PsVs from the different PV genera used in the analysis, and it can be seen that they all possessed at least one extended (FY)xNPxF/Y motif and up to three minimal NPxF/Y motifs. Immortalized human keratinocyte HaCaT cells were first transiently silenced with SNX17 small interfering RNA (siRNA) and then exposed to the relevant PsVs. Luciferase activity was compared with that obtained in cells silenced with irrelevant HPV-18 E6/E7 siRNA (siCTRL). As shown in Fig. 2B , the infectivity of all PsVs was significantly reduced in SNX17-silenced HaCaT cells (P Ͻ 0.0001; one-way analysis of variance [ANOVA]). Infectivity did not correlate with the number of potential SNX17 binding sites, suggesting that the mode of L2-SNX17 interaction is similar throughout the PV genera. Detailed analysis of PV infectivity revealed that none of the PV types was affected in a significantly different way; nevertheless, PVs of genus Alpha appear to be more susceptible to SNX17 ablation than the group of PVs from other genera (P Ͻ 0.0001; one-way ANOVA and Turkey's multiple comparison test). To exclude the possibility that the decrease in infectivity reflected compromised endocytosis or other vital cellular functions as a consequence of SNX17 silencing, we included in the study PsVs of Merkel cell polyomavirus (MCV), which does not have an NPxF/Y motif in any of the capsid proteins, VP1 and VP2/3 (18) . Surprisingly, luciferase activity was even higher in SNX17-silenced HaCaTs than in the siCTRL, implying an enhanced level of infectivity. To explore the possibility that SNX17 could potentially have different roles in infection with different viruses and different cell lines, we extended the study to two additional cell lines: HEK293 and human osteosarcoma U2OS cells. The results showed that MCV infectivity in HEK293 and U2OS cells was not affected by SNX17 silencing (Fig. 2C) , while the reduction of HPV-16 infection was consistent with that observed in HaCaTs. Statistical analyses confirmed that luciferase expression was highly dependent on the virus type (P Ͻ 0.0001); however, differences observed in the three lines were not significant (P ϭ 0.392; two-way ANOVA and Bonferroni multiple comparison test). We concluded that the infectivity of MCV is in general not affected by SNX17 silencing, suggesting that the observed reduction in PV infectivity following SNX17 silencing is directly related to the interaction between L2 and SNX17.
While the potential receptors and the mode of endocytosis are still highly questionable, a majority of studies agree that exposure to low pH in late endosomes or lysosomes is critical for viral uncoating and, consequently, for efficient PV infection (3, 5, 8, 19) . In the case of the HPV-16 L2 interaction with SNX17, this seems to aid lysosomal escape (12) . Here, we conducted a comparative study of a broad range of PV types and showed that the capacity of L2 to interact with SNX17 was conserved across diverse PV types. Furthermore, SNX17 was essential for infection by PVs derived from the Alpha, Beta, Delta, Kappa, and Pi genera. Our study suggested that regardless of the first entry steps, the viral L2 protein encounters SNX17 at some time during the process of PV trafficking and uncoating, when the L2 protein is exposed and available for binding with SNX17. This defines the L2-SNX17 interaction and its subsequent consequences as a common feature of all PVs, thus highlighting a critical step in the viral infectious process.
